Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortalityDalila Costa, Thomas Reiberger, Benedikt Simbrunner et al.|Journal of Hepatology|2020Cited by 202
Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomesMathias Jachs, Thomas Reiberger, Albert Friedrich Stättermayer et al.|Gut|2020Cited by 98
The Sequential Application of Baveno VII Criteria and VITRO Score Improves Diagnosis of Clinically Significant Portal HypertensionMathias Jachs, Mattias Mandorfer, Lukas Hartl et al.|Clinical Gastroenterology and Hepatology|2022Cited by 79
Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID‐19 in patients with chronic liver diseaseLukas Hartl, Michael Trauner, Katharina Haslinger et al.|Hepatology|2022Cited by 74
Response‐guided long‐term treatment of chronic hepatitis D patients with bulevirtide—results of a “real world” studyMathias Jachs, Péter Ferenci, Caroline Schwarz et al.|Alimentary Pharmacology & Therapeutics|2022Cited by 73